Strengthening our capabilities
Modern technology is edging us closer to truly predictive disease modelling and precision targeting of therapies. This includes computational systems for bioinformatics analysis of massive data-sets, which will define health profiles for million of people.
We are investing in areas such as metabolomics to predict disease risk and efficacy of therapies.
We require state of the art equipment that analyses blood cells to identify biomarkers, that will one day be used in routine tests.
Other major needs are powerful imaging equipment to precisely detect disease in its early stages.
These tools also enable us to trial targeted methods to stabilise plaques in your blood vessels — preventing heart attacks years in advance.